On Wednesday, FedEx Corporation (NYSE:FDX)’s shares declined -1.15% to $169.52.
On April 13, FedEx Corporation released Frost & Sullivan research on the dynamics shaping the future healthcare supply chain. The study, “Improving Profitability, Improving Customer Loyalty, Improving Lives,” indicated that supply chain is a growing and important differentiator for companies in the fast changing $3 trillion healthcare sector.
“Consolidation and other changes within the sector means healthcare companies are experiencing growing financial and pricing pressure,” said Carl Asmus, vice president, Global Supply Chain Solutions and Market Development, FedEx Services. “More healthcare companies are using their supply chain as a way to stand out from their competitors and realize their financial aims.”
Over 80 percent of healthcare supply chain executives surveyed at FedEx HealthCare Executive Forum agree supply chain is ‘extremely important’ to reaching profitability targets (89 percent) and revenue targets (83 percent), while 61 percent agree cost reduction strategies in the supply chain have been ‘extremely important’ in responding to customer pricing pressure.
FedEx Corporation provides transportation, e-commerce, and business services in the United States and internationally. The company’s FedEx Express segment provides various shipping services for the delivery of packages and freight; international trade services specializing in customs brokerage, and ocean and air freight forwarding services; international trade advisory services, such as assistance with the customs-trade partnership against terrorism program; and customs clearance services, in addition to global trade data, an information tool that allows customers to track and manage imports.
Bank of America Corp (NYSE:BAC)’s shares dropped -1.14% to $15.64, during the last trading session on Wednesday.
Yesterday, Bank of America Corp (BAC), stated net income of $3.4 billion, or $0.27 per diluted share, for the first quarter of 2015, contrast to a loss of $276 million, or $0.05 per share, in the year-ago period.
Revenue, net of interest expense, on an FTE basis, declined $1.3 billion from the first quarter of 2014 to $21.4 billion(G). Nearly $1 billion of this decline was related to a $757 million reduction in equity investment income as the preceding year comprised of a gain on sale of a portion of an equity investment, and $211 million was related to additional market-related adjustments on the company’s debt securities portfolio due to the influence of lower long-term interest rates. Not including these two items, in addition to net debit valuation adjustments (DVA) in both periods, revenue reduced 1 percent to $21.9 billion in the first quarter of 2015 from $22.1 billionin the year-ago quarter(H).
“At a time of continued low interest rates, we had good expense control as we focus on responsible growth with a balanced platform to create long-term value for customers and shareholders.”
Bank of America Corporation, through its auxiliaries, provides banking and financial products and services for individual consumers, small and middle market businesses, institutional investors, large corporations, and governments worldwide. The company operates through Consumer & Business Banking; Consumer Real Estate Services; Global Wealth & Investment Administration; Global Banking; Global Markets; and Legacy Assets & Servicing segments.
At the end of Wednesday’s trade, Express Scripts Holding Company (NASDAQ:ESRX)‘s shares dipped -1.14% to $87.06.
On April 8, Express Scripts Holding Company (ESRX), declared its intention to release its first quarter earnings on Tuesday, April 28, 2015 after the market closes and will hold its quarterly conference call to talk about first quarter results on Wednesday, April 29, 2015, at 8:30 a.m. Eastern Time (7:30 a.m. Central Time).
Express Scripts Holding Company operates as a pharmacy benefit administration (PBM) company in the United States and Canada. The company operates through two segments, PBM and Other Business Operations. The company’s PBM segment’s services comprise clinical solutions to enhance health outcomes, such as adherence, case coordination, and personalized medicine; specialized pharmacy care; home delivery pharmacy; specialty pharmacy, counting the distribution of fertility pharmaceuticals that require special handling or packaging; and retail network pharmacy administration.
International Game Technology (NYSE:IGT), ended its Wednesday’s trading session with -1.12% loss, and closed at $20.32.
Yesterday, International Game Technology (IGT), declared that its partner GTECH Corporation (“the Company”) has reached a contract with the Minnesota State Lottery to provide new lottery technology, an IP-communications network, multimedia displays, self-service products, and ongoing support services, following a competitive procurement. The 7.5 year integrated services contract with the Lottery contains three renewal options of one year each, or up to one renewal of three years, or any variation thereof.
The Company anticipates to receive about $75 million to $80 million in revenues over the base 7.5 year contract period, which runs through August 9, 2023. The Minnesota State Lottery has been a valued customer since 2003.
The Company will maintain its primary data center in Roseville, Minnesota, and its backup data center in Austin, Texas, providing ongoing services such as operation and maintenance of the central system; maintenance of the terminals and communications network; field services; retailer training; and hotline administration.
International Game Technology, a gaming company, designs, develops, manufactures, and markets casino-style gaming equipment, systems technology, and game content for land-based and online markets worldwide. The company operates in two segments, North America and International.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
